Table 2 Prescription patterns of comorbidity-relevant medication at baseline
Individuals with prescriptions of therapeutic agents for comorbid conditions | ||
|---|---|---|
N | % | |
Treatment of heart insufficiency/cardiac arrhythmia | 11,267 | 30.6 |
Digitalis glycosides (ATC code C01AA) | 1516 | 4.1 |
Anti-arrhythmic drugs (ATC code C01BD) | 541 | 1.5 |
Diuretic drugs (ATC code C03) | 10,631 | 28.8 |
Treatment of cardiovascular disease | 19,376 | 52.6 |
Statins (ATC code C10AA) | 5881 | 16.0 |
Beta-blockers (ATC code C07) | 11,038 | 30.0 |
ACE inhibitors (ATC codes C09AA C09B) | 9309 | 25.3 |
Antiotensin-I-antagonists (ATC codes C09CA C09D) | 4664 | 12.7 |
Treatment with anti-clotting medication | 7692 | 20.9 |
Antiplatelet drugs (ATC code B01AC) | 4071 | 11.1 |
Vitamin-K antagonists (ATC code B01AB) | 2428 | 6.60 |
Heparin (−derivates) (ATC code B01AA) | 2285 | 6.2 |
Treatment with anti-acid drugs | 14,596 | 39.6 |
Proton-pump inhibitors (PPI) (ATC code A02BC) | 14,171 | 38.5 |
Histamine-H2 blockers (ATC code A02BA) | 463 | 1.3 |
Treatment with anti-depressants (ATC code N06A) | 3952 | 10.7 |
Treatment with anti-diabetic drugs (ATC codes A10A, A10B) | 5891 | 16.0 |
Treatment with drugs against obstructive airway disease | 11,021 | 29.9 |
Long-acting beta2 agonists (LABA) (ATC code R03AC) | 2640 | 7.2 |
Long-acting muscarinic antagonists (LAMA) (ATC code R03BB) | 4690 | 12.7 |
Inhaled corticosteroids (ICS) (ATC code R03BA) | 2794 | 7.6 |
Combination product LABA/ICS (ATC code R03AK) | 5135 | 13.9 |
Combination product LABA/LAMA (ATC code R03AL) | 40 | 0.1 |
Treatment with specific PH drugs (ATC codes G04BE03, B01AC09, C03KX) | 265 | 0.7 |